** UoH start-up introduces Covid treatment through stem cells

Transcell Oncologics, a biotech startup company incubated at ASPIRE-Technology Business Incubator (ASPIRE-TBI), University of Hyderabad (UoH), on Monday announced a breakthrough human umbilical cord tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs) based therapy to Covid patients, a press release from UoH said.

Dr Subadra Dravida, Founder CEO, Transcell 

Leave a Reply

Your email address will not be published. Required fields are marked *